203 related articles for article (PubMed ID: 10469609)
21. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
22. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
Borie C; Colas C; Dartigues P; Lazure T; Rince P; Buhard O; Folliot P; Chalastanis A; Muleris M; Hamelin R; Mercier D; Oliveira C; Seruca R; Chadburn A; Leblond V; Barete S; Gaïdano G; Martin A; Gaulard P; Fléjou JF; Raphael M; Duval A
Int J Cancer; 2009 Nov; 125(10):2360-6. PubMed ID: 19551857
[TBL] [Abstract][Full Text] [Related]
23. Genetics of N-methyl-N-nitrosourea induction of thymic lymphomas in AKR/J mice: assignment of a susceptibility gene to mouse chromosome 7.
Angel JM; Morizot DC; Richie ER
J Natl Cancer Inst; 1989 Nov; 81(21):1652-5. PubMed ID: 2552132
[TBL] [Abstract][Full Text] [Related]
24. N-methyl-N-nitrosourea-induced T-lymphomas of AKR/J mice contain somatically acquired ecotropic-like murine leukemia proviruses.
Richie ER; Angel JM; McEntire B
Virology; 1988 May; 164(1):211-9. PubMed ID: 2834870
[TBL] [Abstract][Full Text] [Related]
25. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes.
Kawate H; Sakumi K; Tsuzuki T; Nakatsuru Y; Ishikawa T; Takahashi S; Takano H; Noda T; Sekiguchi M
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5116-20. PubMed ID: 9560238
[TBL] [Abstract][Full Text] [Related]
26. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.
Felsberg J; Thon N; Eigenbrod S; Hentschel B; Sabel MC; Westphal M; Schackert G; Kreth FW; Pietsch T; Löffler M; Weller M; Reifenberger G; Tonn JC;
Int J Cancer; 2011 Aug; 129(3):659-70. PubMed ID: 21425258
[TBL] [Abstract][Full Text] [Related]
27. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
Campbell MR; Thang TY; Jirik FR; Andrew SE
Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
[TBL] [Abstract][Full Text] [Related]
28. DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors.
Becker K; Gregel C; Fricke C; Komitowski D; Dosch J; Kaina B
Carcinogenesis; 2003 Mar; 24(3):541-6. PubMed ID: 12663516
[TBL] [Abstract][Full Text] [Related]
29. Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.
Parsons BL; Delongchamp RR; Beland FA; Heflich RH
Mutagenesis; 2006 Jan; 21(1):29-34. PubMed ID: 16314341
[TBL] [Abstract][Full Text] [Related]
30. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure.
Reese JS; Qin X; Ballas CB; Sekiguchi M; Gerson SL
J Hematother Stem Cell Res; 2001 Feb; 10(1):115-23. PubMed ID: 11276365
[TBL] [Abstract][Full Text] [Related]
31. Methylation damage response in hematopoietic progenitor cells.
Casorelli I; Pelosi E; Biffoni M; Cerio AM; Peschle C; Testa U; Bignami M
DNA Repair (Amst); 2007 Aug; 6(8):1170-8. PubMed ID: 17507295
[TBL] [Abstract][Full Text] [Related]
32. Rev1 overexpression accelerates N-methyl-N-nitrosourea (MNU)-induced thymic lymphoma by increasing mutagenesis.
Sasatani M; Xi Y; Daino K; Ishikawa A; Masuda Y; Kajimura J; Piao J; Zaharieva EK; Honda H; Zhou G; Hamasaki K; Kusunoki Y; Shimura T; Kakinuma S; Shimada Y; Doi K; Ishikawa-Fujiwara T; Sotomaru Y; Kamiya K
Cancer Sci; 2024 Jun; 115(6):1808-1819. PubMed ID: 38572512
[TBL] [Abstract][Full Text] [Related]
33. Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell.
Liu L; Qin X; Gerson SL
Carcinogenesis; 1999 Feb; 20(2):279-84. PubMed ID: 10069465
[TBL] [Abstract][Full Text] [Related]
34. Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4.
Angel JM; Richie ER
Mol Carcinog; 2002 Feb; 33(2):105-12. PubMed ID: 11813303
[TBL] [Abstract][Full Text] [Related]
35. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.
Sakumi K; Shiraishi A; Shimizu S; Tsuzuki T; Ishikawa T; Sekiguchi M
Cancer Res; 1997 Jun; 57(12):2415-8. PubMed ID: 9192819
[TBL] [Abstract][Full Text] [Related]
36. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the relationship between microsatellite instability and thymic lymphoma induced by N-methyl-N-nitrosourea in C57BL/6J mice.
Huo X; Zhang S; Li Z; Gao J; Wang C; Li C; Guo M; Du X; Chen Z
Mutat Res; 2015 Jan; 771():21-8. PubMed ID: 25771976
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
39. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis.
Baker SM; Bronner CE; Zhang L; Plug AW; Robatzek M; Warren G; Elliott EA; Yu J; Ashley T; Arnheim N; Flavell RA; Liskay RM
Cell; 1995 Jul; 82(2):309-19. PubMed ID: 7628019
[TBL] [Abstract][Full Text] [Related]
40. Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA
Mol Carcinog; 2000 Jun; 28(2):97-101. PubMed ID: 10900466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
